Planning Capital Management Corporation’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$101 Hold
2
﹤0.01% 721
2024
Q2
$88 Buy
+2
New +$88 ﹤0.01% 668